Zynex Sets Second Quarter 2025 Earnings Call
Zynex (NASDAQ: ZYXI), a medical technology company focused on non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has scheduled its Q2 2025 earnings conference call for July 31, 2025, at 4:15 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zynex (NASDAQ: ZYXI), a medical technology company focused on non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has scheduled its Q2 2025 earnings conference call for July 31, 2025, at 4:15 PM ET.
The company will release its financial results for the quarter ended June 30, 2025, before the call. Management will host the call followed by a Q&A session. Participants can join via phone using the U.S. & Canada dial-in (800-836-8184) or international number (646-357-8785), or through the webcast available on the company's investor relations website.
Details
News Market Reaction – ZYXI
The recorded move for ZYXI in the trading session of this news was +4.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Zynex management will host the conference call, followed by a question and answer session.
Date: Thursday, July 31, 2025
Time: 4:15 PM Eastern Time (2:15 PM Mountain Time)
International number: 646-357-8785
Webcast: Q2-2025 Webcast Link
The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.
About Zynex, Inc.
Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.
Investor Relations Contact:
Dan Moorhead, CFO
ir@zynex.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-sets-second-quarter-2025-earnings-call-302510532.html
SOURCE Zynex, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.